Ronald Roth
Cardiovascular Disease · Parowan, UTNPI 1497795389
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,893 and has fallen 99.1% since, to $18 in 2024.
Across 136 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$433
- Johnson & Johnson$290
- Sanofi-aventis U.S. LLC$255
- Novartis$243
- Boehringer Ingelheim$199
- Pfizer$151
- plus $775 from 14 others
What the payments were for
- Food & beverage$2,32099%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 24 | $433 |
| Johnson & Johnson | 20 | $290 |
| Sanofi-aventis U.S. LLC | 14 | $255 |
| Novartis | 17 | $243 |
| Boehringer Ingelheim | 12 | $199 |
| Pfizer | 4 | $151 |
| AstraZeneca | 8 | $142 |
| E.r. Squibb & Sons, L.L.C. | 7 | $111 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Actelion Pharmaceuticals US, Inc. | 4 | $74 |
| Amarin Pharma, Inc. | 4 | $66 |
| Arbor Pharmaceuticals, Inc. | 3 | $60 |
| Abbott | 3 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Portola Pharmaceuticals, LLC | 3 | $37 |
| Braemar Manufacturing, LLC | 1 | $26 |
| Medtronic | 1 | $19 |
| Astellas Pharma US Inc | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYNDAQEL$107
How this compares
$2,346 in reported general payments places this provider in the 55th percentile of 131 cardiovascular disease providers in Utah.
Other cardiovascular disease in Parowan
- John RyanSalt Lake City$1.4M
- Robert FowlesSalt Lake City$611K
- Brian WhisenantMurray$416K
- Andrew BehuninDraper$192K
- Jeffrey OsbornSalt Lake City$69K
- James FangSalt Lake City$67K
- Joseph MuhlesteinMurray$65K
- Hannah RaaschSalt Lake City$62K
- Divya Ratan VermaMurray$47K
- Daniel VarelaSt George$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.